384 related articles for article (PubMed ID: 26426047)
1. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Studies Reveal the Molecular Basis for GABA
Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ
ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088
[TBL] [Abstract][Full Text] [Related]
3. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
[TBL] [Abstract][Full Text] [Related]
4. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
Nevin ST; Clark RJ; Klimis H; Christie MJ; Craik DJ; Adams DJ
Mol Pharmacol; 2007 Dec; 72(6):1406-10. PubMed ID: 17804600
[TBL] [Abstract][Full Text] [Related]
5. α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement.
Chu X; Tae HS; Xu Q; Jiang T; Adams DJ; Yu R
ACS Chem Neurosci; 2019 Oct; 10(10):4328-4336. PubMed ID: 31411453
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain.
Klimis H; Adams DJ; Callaghan B; Nevin S; Alewood PF; Vaughan CW; Mozar CA; Christie MJ
Pain; 2011 Feb; 152(2):259-266. PubMed ID: 20889259
[TBL] [Abstract][Full Text] [Related]
7. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
[TBL] [Abstract][Full Text] [Related]
8. Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice.
Callaghan B; Adams DJ
Channels (Austin); 2010; 4(1):51-4. PubMed ID: 20368690
[TBL] [Abstract][Full Text] [Related]
9. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
[TBL] [Abstract][Full Text] [Related]
10. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
[TBL] [Abstract][Full Text] [Related]
11. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors.
Vincler M; Wittenauer S; Parker R; Ellison M; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17880-4. PubMed ID: 17101979
[TBL] [Abstract][Full Text] [Related]
13. Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models.
Kryukova EV; Ivanov IA; Lebedev DS; Spirova EN; Egorova NS; Zouridakis M; Kasheverov IE; Tzartos SJ; Tsetlin VI
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469507
[TBL] [Abstract][Full Text] [Related]
14. Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype.
Yu R; Tae HS; Tabassum N; Shi J; Jiang T; Adams DJ
J Med Chem; 2018 May; 61(10):4628-4634. PubMed ID: 29733583
[TBL] [Abstract][Full Text] [Related]
15. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
[TBL] [Abstract][Full Text] [Related]
16. Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
Yu R; Kompella SN; Adams DJ; Craik DJ; Kaas Q
J Med Chem; 2013 May; 56(9):3557-67. PubMed ID: 23566299
[TBL] [Abstract][Full Text] [Related]
17. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor.
Li X; Tae HS; Chu Y; Jiang T; Adams DJ; Yu R
Pharmacol Ther; 2021 Jun; 222():107792. PubMed ID: 33309557
[TBL] [Abstract][Full Text] [Related]
18. The α9α10 nicotinic acetylcholine receptors antagonist α-conotoxin RgIA reverses colitis signs in murine dextran sodium sulfate model.
AlSharari SD; Toma W; Mahmood HM; Michael McIntosh J; Imad Damaj M
Eur J Pharmacol; 2020 Sep; 883():173320. PubMed ID: 32645334
[TBL] [Abstract][Full Text] [Related]
19. Targeting of N-Type Calcium Channels via GABA
Cai F; Xu N; Liu Z; Ding R; Yu S; Dong M; Wang S; Shen J; Tae HS; Adams DJ; Zhang X; Dai Q
J Med Chem; 2018 Nov; 61(22):10198-10205. PubMed ID: 30358401
[TBL] [Abstract][Full Text] [Related]
20. From Crystal Structures of RgIA4 in Complex with
Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X
Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]